Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health

生命早期心血管疾病危险因素、表观遗传年龄加速和阿尔茨海默病相关的大脑健康

基本信息

  • 批准号:
    10706044
  • 负责人:
  • 金额:
    $ 70.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Dementia is a major global health challenge, and Alzheimer’s disease (AD) comprises 70% of dementia cases. Because AD has no effective treatment options, the Lancet Commission recently emphasized the critical need for effective, life-course prevention of AD. Epigenetic age acceleration (EAA), or increased DNA methylation (DNAm)-based age relative to chronological age, was identified as a powerful biomarker of AD-related neurobiological substrates and cognitive function in older adults. Likewise, our preliminary data demonstrated associations between EAA and cognitive function in midlife, a critical epoch in brain health when subclinical pathology first emerges, and dementia prevention may be most effective. Works by us and others have also identified associations between cardiovascular disease (CVD) risk factors and EAA, suggesting that EAA could help to explain the intricate link between early life heart and midlife brain health. Despite these intriguing data, prospective associations between childhood CVD risk factors and EAA in adulthood remain unknown and temporal associations are not established. In addition, there is a paucity of research examining the relationships of EAA with midlife cognitive function decline and AD-related neurobiological substrates. We hypothesize that EAA is associated with cognitive decline and neurobiological substrates in midlife and mediates the associations of early life CVD risk factors with these midlife brain health endpoints. To test this hypothesis, we will leverage the rich resources of the Bogalusa Heart Study (BHS), including life-long measures of CVD risk factors, three repeated measures of genome-wide DNAm in adulthood, and two midlife measures of cognitive function over 11-years follow-up in the full cohort of 1,298 BHS participants (850 whites and 448 African Americans). Furthermore, midlife AD-related neurobiological substrates from 3T magnetic resonance imaging (MRI) and amyloid photon emission tomography (PET) scans are also available in a random subsample of 350 BHS participants. As part of the on-going visit cycle (2020-2024), we propose MRI in another random subsample of 350 BHS participants, amyloid PET scans in another random subsample of 50 participants, along with an additional genome-wide DNAm measure in the full BHS cohort. With these data, we will assess prospective and temporal associations of early life CVD risk factors with EAA (Aim 1); examine the associations of EAA with 11-year changes in cognitive function (Aim 2) and neurobiological substrates in midlife (Aim 3); and analyze the mediating effects of EAA on associations of childhood CVD risk factors with midlife brain health endpoints (Aim 4). The molecular characterization of midlife brain health may have broad implications, ranging from the improvement of risk stratification and sub-phenotyping efforts to the pinpointing of molecular targets for drug development. Identifying CVD risk factor precursors to EAA might suggest optimal strategies to prevent EAA and its brain-related sequelae.
摘要 痴呆症是一个主要的全球健康挑战,阿尔茨海默病(AD)占痴呆症病例的70%。 由于AD没有有效的治疗选择,柳叶刀委员会最近强调了迫切需要 有效地预防AD的终生发生。表观遗传年龄加速(EAA)或DNA甲基化增加 基于DNA m的年龄相对于实足年龄,被确定为AD相关性的强有力的生物标志物。 老年人的神经生物学基质和认知功能。同样,我们的初步数据 证明了EAA和中年认知功能之间的联系,这是大脑健康的关键时期, 亚临床病理学首先出现,痴呆症的预防可能是最有效的。我们和其他人的作品 还确定了心血管疾病(CVD)风险因素与EAA之间的关联,表明 EAA可以帮助解释早期心脏和中年大脑健康之间的复杂联系。尽管有这些 有趣的数据,儿童期CVD危险因素与成年期EAA之间的前瞻性关联仍然存在, 不建立未知和时间关联。此外,还缺乏研究, EAA与中年认知功能减退及AD相关神经生物学底物的关系。我们 假设EAA与中年认知能力下降和神经生物学底物有关, 介导早期CVD风险因素与这些中年大脑健康终点的关联。为了验证这一 假设,我们将利用博加卢萨心脏研究(BHS)的丰富资源,包括终身 CVD危险因素的测量,成年期全基因组DNAm的三次重复测量,以及中年期的两次重复测量。 对1,298名BHS参与者(850名白人)进行了为期11年的随访, 448名美国人)。此外,来自3 T磁共振成像的中年AD相关神经生物学底物 核磁共振成像(MRI)和淀粉样蛋白光子发射断层扫描(PET)扫描也可在 随机抽取350名BHS参与者。作为持续访视周期(2020-2024)的一部分,我们建议进行MRI检查 在另一个350名BHS参与者的随机子样本中, 50名参与者,沿着在整个BHS队列中进行额外的全基因组DNA m测量。有了这些数据, 我们将评估早期生命CVD危险因素与EAA(目标1)的前瞻性和时间相关性; EAA与认知功能(目标2)和神经生物学底物的11年变化的相关性, 中年(目标3);并分析EAA对儿童心血管疾病危险因素与 中年脑健康终点(目标4)。中年大脑健康的分子特征可能具有广泛的 影响,从改善风险分层和亚表型的努力,以查明 用于药物开发的分子靶点。识别EAA的心血管疾病风险因素前体可能表明最佳 预防EAA及其脑相关后遗症的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lydia Bazzano其他文献

Lydia Bazzano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lydia Bazzano', 18)}}的其他基金

I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia
I3C 十年:儿童心血管暴露和阿尔茨海默氏痴呆的差异和公平
  • 批准号:
    10653088
  • 财政年份:
    2022
  • 资助金额:
    $ 70.86万
  • 项目类别:
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia
I3C 十年:儿童心血管暴露和阿尔茨海默氏痴呆的差异和公平
  • 批准号:
    10449003
  • 财政年份:
    2022
  • 资助金额:
    $ 70.86万
  • 项目类别:
Tulane University Training Program for Diversity in tRanslation and Implementation research in cardioVascular disEase (DRIVE)
杜兰大学心血管疾病翻译和实施研究多样性培训计划 (DRIVE)
  • 批准号:
    10255155
  • 财政年份:
    2021
  • 资助金额:
    $ 70.86万
  • 项目类别:
Tulane University Training Program for Diversity in tRanslation and Implementation research in cardioVascular disEase (DRIVE)
杜兰大学心血管疾病翻译和实施研究多样性培训计划 (DRIVE)
  • 批准号:
    10646467
  • 财政年份:
    2021
  • 资助金额:
    $ 70.86万
  • 项目类别:
Tulane University Training Program for Diversity in tRanslation and Implementation research in cardioVascular disEase (DRIVE)
杜兰大学心血管疾病翻译和实施研究多样性培训计划 (DRIVE)
  • 批准号:
    10432093
  • 财政年份:
    2021
  • 资助金额:
    $ 70.86万
  • 项目类别:
Supplemental Funding Request for RF1 AG062309 Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
RF1 AG062309 的补充资金申请 早期血糖状态和中年阿尔茨海默病神经影像标记:Bogalusa 心脏研究
  • 批准号:
    10161514
  • 财政年份:
    2019
  • 资助金额:
    $ 70.86万
  • 项目类别:
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
早期血糖状况和中年阿尔茨海默病神经影像学标志物:Bogalusa 心脏研究
  • 批准号:
    10064986
  • 财政年份:
    2019
  • 资助金额:
    $ 70.86万
  • 项目类别:
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
早期血糖状况和中年阿尔茨海默病神经影像学标志物:Bogalusa 心脏研究
  • 批准号:
    10318574
  • 财政年份:
    2019
  • 资助金额:
    $ 70.86万
  • 项目类别:
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
早期血糖状况和中年阿尔茨海默病神经影像学标志物:Bogalusa 心脏研究
  • 批准号:
    10535457
  • 财政年份:
    2019
  • 资助金额:
    $ 70.86万
  • 项目类别:
A novel research infrastructure enabling life-course studies of healthy aging
新型研究基础设施可实现健康老龄化的生命历程研究
  • 批准号:
    9756284
  • 财政年份:
    2018
  • 资助金额:
    $ 70.86万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了